Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis. (February 2020)
- Record Type:
- Journal Article
- Title:
- Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis. (February 2020)
- Main Title:
- Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis
- Authors:
- Ma, M.-J.
Wang, X.-X.
Wu, M.-N.
Wang, X.-J.
Bao, C.-J.
Zhang, H.-J.
Yang, Y.
Xu, K.
Wang, G.-L.
Zhao, M.
Cheng, W.
Chen, W.-J.
Zhang, W.-H.
Fang, L.-Q.
Liu, W.J.
Chen, E.-F.
Cao, W.-C. - Abstract:
- Abstract: Objectives: Despite the importance of immunological memory for protective immunity against viral infection, whether H7N9-specific antibodies and memory T-cell responses remain detectable years after the original infection is unknown. Methods: A cross-sectional study was conducted to investigate the immune memory responses of H7N9 patients who contracted the disease and survived during the 2013–2016 epidemics in China. Sustainability of antibodies and T-cell memory to H7N9 virus were examined. Healthy individuals receiving routine medical examinations in a physical examination centre were recruited as control. Results: A total of 75 survivors were enrolled and classified into four groups based on the time elapsed from illness onset to specimen collection: 3 months ( n = 14), 14 months ( n = 14), 26 months ( n = 28) and 36 months ( n = 19). Approximately 36 months after infection, the geometric mean titres of virus-specific antibodies were significantly lower than titres in patients 3 months after infection, but 16 of 19 (84.2%) survivors in the 36-month interval had microneutralization (MN) titres ≥40. Despite the overall declining trend, the percentages of virus-specific cytokine-secreting memory CD4 + and CD8 + T cells remained higher in survivors at nearly all time-points in comparison with control individuals. Linear regression analysis showed that severe disease (mean titre ratio 2.77, 95% CI 1.17–6.49) was associated with higher haemagglutinationAbstract: Objectives: Despite the importance of immunological memory for protective immunity against viral infection, whether H7N9-specific antibodies and memory T-cell responses remain detectable years after the original infection is unknown. Methods: A cross-sectional study was conducted to investigate the immune memory responses of H7N9 patients who contracted the disease and survived during the 2013–2016 epidemics in China. Sustainability of antibodies and T-cell memory to H7N9 virus were examined. Healthy individuals receiving routine medical examinations in a physical examination centre were recruited as control. Results: A total of 75 survivors were enrolled and classified into four groups based on the time elapsed from illness onset to specimen collection: 3 months ( n = 14), 14 months ( n = 14), 26 months ( n = 28) and 36 months ( n = 19). Approximately 36 months after infection, the geometric mean titres of virus-specific antibodies were significantly lower than titres in patients 3 months after infection, but 16 of 19 (84.2%) survivors in the 36-month interval had microneutralization (MN) titres ≥40. Despite the overall declining trend, the percentages of virus-specific cytokine-secreting memory CD4 + and CD8 + T cells remained higher in survivors at nearly all time-points in comparison with control individuals. Linear regression analysis showed that severe disease (mean titre ratio 2.77, 95% CI 1.17–6.49) was associated with higher haemagglutination inhibition (HI) titre and female sex for both HI (1.92, 1.02–3.57) and MN (3.33, 1.26–9.09) antibody, whereas female sex (mean percentage ratio 1.69, 95% CI 1.08–2.63), underlying medical conditions (1.94, 95% CI 1.09–3.46) and lack of antiviral therapy (2.08, 95% CI 1.04–4.17) were predictors for higher T-cell responses. Conclusions: Survivors of H7N9 virus infection produced long-term antibodies and memory T-cell responses. Our findings warrant further serological investigation in general and high-risk populations and have important implications for vaccine design and development. … (more)
- Is Part Of:
- Clinical microbiology and infection. Volume 26:Number 2(2020)
- Journal:
- Clinical microbiology and infection
- Issue:
- Volume 26:Number 2(2020)
- Issue Display:
- Volume 26, Issue 2 (2020)
- Year:
- 2020
- Volume:
- 26
- Issue:
- 2
- Issue Sort Value:
- 2020-0026-0002-0000
- Page Start:
- 247
- Page End:
- 254
- Publication Date:
- 2020-02
- Subjects:
- Antibodies -- H7N9 -- Immune Memory -- Influenza -- Survivors -- T cells
Medical microbiology -- Periodicals
Diagnostic microbiology -- Periodicals
Communicable diseases -- Periodicals
Infection -- Periodicals
616.01 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1469-0691 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1016/j.cmi.2019.06.013 ↗
- Languages:
- English
- ISSNs:
- 1198-743X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.305520
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 12814.xml